Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

NCT05303792 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

B Acute Lymphoblastic Leukemia
B Lymphoblastic Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Mercaptopurine
DRUG: Doxorubicin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]